EchoNous

Executive Summary

EchoNous is a Redmond-based private company developing AI-powered point-of-care ultrasound (POCUS) tools aimed at primary care and emergency settings. Founded in 2016, the company addresses the need for affordable, easy-to-use ultrasound devices that can assist non-specialists in making rapid diagnoses. Its lead product, the KOSMOS platform, combines a handheld ultrasound probe with AI-driven guidance and interpretation software. This solution targets common clinical problems like cardiac assessment, lung evaluation, and fluid detection. EchoNous has received FDA clearance for some applications and is expanding into new clinical areas. The company’s technology has the potential to democratize ultrasound access, reducing costs and improving patient outcomes. With growing adoption of POCUS and telehealth, EchoNous is well-positioned. However, it faces competition from established players like Butterfly Network and GE Healthcare. Financially, the company remains private and may seek additional funding or strategic partnerships. Overall, EchoNous offers a compelling value proposition in the digital health space.

Upcoming Catalysts (preview)

• H2 2026FDA clearance for expanded clinical applications (e.g., lung or DVT)70% success
• Q4 2026Strategic partnership with a major healthcare system or distributor50% success
• Q1 2027Launch of next-generation hardware or software update60% success